Search
for
Sort by
Research 961–990 of 1000+
- Post-steroid panniculitis: a lost and forgotten entity?
- Trilostane Treatment of Canine Alopecia X in an American Pit Bull Terrier
- Untersuchungen der Fremdstoffbindung in permanenten Keratinozyten- und Melanozyten-Zelllinien sowie die Eignung von Primärkulturen aus humanen Haarfollikeln zur In-vitro-Messung der Fremdstoffaufnahme im Haar
- Syndromes of Severe Insulin Resistance (SSIRs)
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Obstetric and Gynecologic Dermatology
- Quantitation of Hepatitis C Virus RNA
- Diagnosing Vascular Causes of Renal Failure
- Liver Cirrhosis and Circadian Rhythm
- National scientific medical meeting 1996 abstracts
- Drug Information Analysis Service
- Abstracts of Communications
- Cutaneous manifestations of systemic infection in children
- Dermatological drugs, topical agents, and cosmetics
- Cytostatics and immunosuppressive drugs
- Biotinidase Deficiency and Seizures
- 1123 COPPER LOADING (CuL) STUDIES IN BRINDLED (Br) MOUSE HEMIZYGOTES AND HETEROZYGOTES
- Chemotherapy in Gynecologic Malignancy
- MOST IMPORTANT SKIN DISEASES OF CHILDRENTheir Diagnosis and Treatment
- MECHANISM OF PROTEINURIA
- Queries and Minor Notes
- A randomized, controlled pilot trial comparing platelet-rich plasma to topical minoxidil foam for treatment of androgenic alopecia in women
- Comparación del efecto terapéutico entre el extracto etanólico del fruto de Physalis peruviana, Finasteride y Terazosine en la hiperplasia prostática benigna inducida en ratas
- Interrelation of immunity and tissue repair or regeneration
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System